Oncology
0 drugs are in development for Stomach Neoplasms.
- Companies
- 0
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Stomach Neoplasms pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Stomach Neoplasms context
Oncology·MeSH: Stomach Neoplasms (D013274)
Also known as: Gastric Neoplasm, Gastric Neoplasms, Neoplasm, Stomach
Narrower concepts tracked separately: Gastric Cancer, Stomach Cancer, Gastric Cancer (GC)
Prevalence
10.0 / 100K
Incidence
6.1 / 100K/yr
Frequently asked questions
How many clinical trials target Stomach Neoplasms?
There are 7 clinical trials targeting Stomach Neoplasms tracked by BioSniper.
What is the prevalence of Stomach Neoplasms?
The estimated prevalence of Stomach Neoplasms is approximately 10.0 per 100,000 population.